NCT04247035

Τreatment Standards and Outcomes of Patients With ER/PR Positive, HER2-negative Metastatic Breast Cancer

Non-Interventional, Multi-center Registry of Recording of Treatment Standards and Outcomes of Patients With ER/PR Positive, HER2-negative Metastatic Breast Cancer

• Status: Unknown
• Phase: —
• Study type: Observational
• Enrollment: 300 (estimated)
• Sponsor: Hellenic Society of Medical Oncology · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

• To capture the treatment patterns and clinical characteristics of patients with ER/PR positive, HER2-negative MBC in Greece

Detailed description

* To capture the treatment patterns and clinical characteristics of patients with ER/PR positive, HER2-negative MBC in Greece * To evaluate the outcome of patients per treatment line (objective response, progression free survival, time to disease progression per line of therapy), overall survival * To record adverse events per line of therapy * To recording of the causes of treatment discontinuation per line of therapy

Conditions

• Metastatic Breast Cancer

Timeline

• Start date: 2019-01-31
• Primary completion: 2022-01-31
• Completion: 2024-01-31
• First posted: 2020-01-29
• Last updated: 2021-02-10

Locations

1 site across 1 country: Greece